PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice

被引:120
作者
Briles, DE [1 ]
King, JD [1 ]
Gray, MA [1 ]
McDaniel, LS [1 ]
Swiatlo, E [1 ]
Benton, KA [1 ]
机构
[1] CONNAUGHT LABS INC,SWIFTWATER,PA 18370
关键词
Streptococcus pneumoniae; PspA vaccine; immunogenicity;
D O I
10.1016/0264-410X(96)82948-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PspA is a surface exposed virulence factor of S. pneumoniae that can elicit protective immunity to pneumococcal sepsis in mice. It can be released from pneumococci by washing them with a solution containing 2% choline chloride, by growing pneumococci in media containing 1.2% choline chloride, or by growing pneumococci in media in which the choline has been replaced by ethanolamine. Our results indicate that PspA is the major protection-eliciting antigen in each of these preparations. Two injections of less than or equal to 1 mu g of native PspA purified by use of a choline-Sepharose column are highly immunogenic in BALB/c and CBA/N mice, and even in the absence of adjuvant can elicit protection against otherwise fatal sepsis with 100 times the LD(50) of S. pneumoniae. Fragments comprising the N-terminal 115 and 245 amino acids of PspA were able to elicit protection but only in the presence of complete Freund's adjuvant (CFA). In the absence of CFA the 245 amino acid fragment was less than 1/100 as immunogenic as native PspA. Copyright (C) Elsevier Science Ltd.
引用
收藏
页码:858 / 867
页数:10
相关论文
共 65 条
[1]   IMMUNIZATION OF MICE WITH PNEUMOLYSIN TOROID CONFERS A SIGNIFICANT DEGREE OF PROTECTION AGAINST AT LEAST 9 SEROTYPES OF STREPTOCOCCUS-PNEUMONIAE [J].
ALEXANDER, JE ;
LOCK, RA ;
PEETERS, CCAM ;
POOLMAN, JT ;
ANDREW, PW ;
MITCHELL, TJ ;
HANSMAN, D ;
PATON, JC .
INFECTION AND IMMUNITY, 1994, 62 (12) :5683-5688
[2]   GENETIC-CONTROL OF ANTIBODY-RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE .1. EVIDENCE THAT AN X-LINKED GENE PLAYS A DECISIVE ROLE IN DETERMINING RESPONSIVENESS [J].
AMSBAUGH, DF ;
BARTHOLD, DR ;
BAKER, PJ ;
STASHAK, PW ;
HANSEN, CT ;
PRESCOTT, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (04) :931-&
[3]   PNEUMOCOCCAL VACCINE - DEVELOPMENT AND PROSPECTS [J].
AUSTRIAN, R .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (04) :547-549
[4]   STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III [J].
Avery, Oswald T. ;
MacLeod, Colin M. ;
McCarty, Maclyn .
JOURNAL OF EXPERIMENTAL MEDICINE, 1944, 79 (02) :137-158
[5]   Chemoimmunological studies on the soluble specific substance of Pneumococcus I. The isolation and properties of the acetyl polysaccharide of Pneumococcus Type I [J].
Avery, OT ;
Goebel, WF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1933, 58 (06) :731-755
[6]   CONTRIBUTION OF AUTOLYSIN TO VIRULENCE OF STREPTOCOCCUS-PNEUMONIAE [J].
BERRY, AM ;
LOCK, RA ;
HANSMAN, D ;
PATON, JC .
INFECTION AND IMMUNITY, 1989, 57 (08) :2324-2330
[7]   ANTIPNEUMOCOCCAL EFFECTS OF C-REACTIVE PROTEIN AND MONOCLONAL-ANTIBODIES TO PNEUMOCOCCAL CELL-WALL AND CAPSULAR ANTIGENS [J].
BRILES, DE ;
FORMAN, C ;
HOROWITZ, JC ;
VOLANAKIS, JE ;
BENJAMIN, WH ;
MCDANIEL, LS ;
ELDRIDGE, J ;
BROOKS, J .
INFECTION AND IMMUNITY, 1989, 57 (05) :1457-1464
[8]   ANTI-PHOSPHOCHOLINE ANTIBODIES FOUND IN NORMAL MOUSE SERUM ARE PROTECTIVE AGAINST INTRAVENOUS INFECTION WITH TYPE-3 STREPTOCOCCUS-PNEUMONIAE [J].
BRILES, DE ;
NAHM, M ;
SCHROER, K ;
DAVIE, J ;
BAKER, P ;
KEARNEY, J ;
BARLETTA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :694-705
[9]   STRONG ASSOCIATION BETWEEN CAPSULAR TYPE AND VIRULENCE FOR MICE AMONG HUMAN ISOLATES OF STREPTOCOCCUS-PNEUMONIAE [J].
BRILES, DE ;
CRAIN, MJ ;
GRAY, BM ;
FORMAN, C ;
YOTHER, J .
INFECTION AND IMMUNITY, 1992, 60 (01) :111-116
[10]  
BRILES DE, 1986, CURR TOP MICROBIOL, V124, P103